Page last updated: 2024-10-31

naphazoline and Lacrimal Duct Obstruction

naphazoline has been researched along with Lacrimal Duct Obstruction in 2 studies

Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
NEMETH, B1
MARTON, D1
TOTH, P1
KUGLER, S1
Lisch, K1

Other Studies

2 other studies available for naphazoline and Lacrimal Duct Obstruction

ArticleYear
[APROPOS OF THE CONSERVATIVE TREATMENT OF LACRIMAL DUCT DISEASES].
    Szemeszet, 1964, Volume: 101

    Topics: Chlortetracycline; Cortisone; Drug Therapy; Eyelids; Fluoresceins; Humans; Lacrimal Apparatus; Lacri

1964
[Conjunctival alterations by sympathomimetic drugs (author's transl)].
    Klinische Monatsblatter fur Augenheilkunde, 1978, Volume: 173, Issue:3

    Topics: Aged; Conjunctiva; Eyelid Diseases; Female; Humans; Imidazoles; Lacrimal Duct Obstruction; Male; Mid

1978